Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01391585 · ClinicalTrials.gov registry record · NA

Expanding Comparative Effectiveness Research (CER) Capability Through Complex Patient Relationship Management

A NA study of Diabetes and Hyperlipidemia, sponsored by Denver Health and Hospital Authority.

Completed
Registry status
NA
Development phase
135
Enrollment target
1
Study location

NCT01391585 is a NA study of Diabetes and Hyperlipidemia that has completed, run by Denver Health and Hospital Authority. The registered enrollment target is 135 participants, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01391585, a NA study of Diabetes and Hyperlipidemia, has completed, sponsored by Denver Health and Hospital Authority.

COMPLETED
Registry status
NA
Development phase
135 participants
Enrollment target
1
Study location

Study Summary

The investigators are testing whether patients with diabetes can communicate with our health care system through text messaging. The investigators will look at how often they respond to prompts for blood pressures, blood sugars, and step counts. The investigators will also see if they come in for lab tests when prompted by text message. Also, for patients overdue for medication refills, the investigators will ask them why they have not yet called for the refill.

Conditions Studied

Interventions

  • OTHER Text Message prompts

Study Locations (1)

Colorado

  • Denver Health - Denver

Trial Details

FieldValue
Enrollment Target 135 participants
Start Date 2011-06
Est. Completion 2012-08
Phase NA

What the Registry Record Tells You About NCT01391585

The ClinicalTrials.gov registry entry for NCT01391585 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 135 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (96% lower). The listed sponsor is Denver Health and Hospital Authority, which has 73 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Diabetes appearing as the primary indexed condition, and to 1 intervention - of which Text Message prompts is the first listed.

NCT01391585 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.

Frequently Asked Questions

What is clinical trial NCT01391585 about?

NCT01391585 is a clinical study titled "Expanding Comparative Effectiveness Research (CER) Capability Through Complex Patient Relationship Management". The investigators are testing whether patients with diabetes can communicate with our health care system through text messaging. The investigators will look at how often they respond to prompts for blood pressures, blood sugars, and step counts. The investigators will also see if they come in for la...

What is the current status of trial NCT01391585?

This trial is currently completed. It is a NA study. The enrollment target is 135 participants. The study started on 2011-06. Estimated completion is 2012-08.

What conditions does trial NCT01391585 study?

This clinical trial studies the following conditions: Diabetes, Hyperlipidemia.

What interventions are being tested in trial NCT01391585?

The interventions under investigation include: Text Message prompts (OTHER).

Who is sponsoring clinical trial NCT01391585?

This trial is sponsored by Denver Health and Hospital Authority, which has 73 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01391585 being conducted?

This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.